Andrew I. Rutherford

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Impact of BMI on response to Janus kinase inhibitors in rheumatoid arthritis: an individual patient data meta-analysis of randomised controlled trials.

Impact of BMI on response to Janus kinase inhibitors in rheumatoid arthritis: an individual patient data meta-analysis of randomised controlled trials.

Journal: The Lancet. Rheumatology

Published: February 25, 2026

Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELY.

Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELY.

Journal: The Lancet. Rheumatology

Published: February 25, 2026

Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study.

Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study.

Journal: Rheumatology (Oxford, England)

Published: March 08, 2025

Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study.

Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study.

Journal: Rheumatology (Oxford, England)

Published: February 19, 2024

No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort.

No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort.

Journal: Vaccines

Published: December 18, 2023

A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis.

A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis.

Journal: Vaccines

Published: September 13, 2023

Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares.

Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares.

Journal: Rheumatology (Oxford, England)

Published: June 28, 2023

Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY.

Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY.

Journal: The Lancet. Rheumatology

Published: June 07, 2023

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications.

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications.

Journal: Annals of the rheumatic diseases

Published: February 17, 2023

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY.

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY.

Journal: The Lancet. Rheumatology

Published: November 30, 2022

Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England.

Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England.

Journal: Rheumatology (Oxford, England)

Published: August 22, 2022

Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom.

Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom.

Journal: The Lancet regional health. Europe

Published: July 11, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026